Agency Information Collection Activities: Proposed Collection; Comment Request, 28056-28057 [2019-12636]
Download as PDF
<![CDATA[
khammond on DSKBBV9HB2PROD with NOTICES
28056
Federal Register / Vol. 84, No. 116 / Monday, June 17, 2019 / Notices
The proposed order contains
injunctive provisions addressing the
alleged unfair conduct in connection
with Respondent’s sale of dealer
management system software and
services. Part I of the proposed order
prohibits Respondent, and any business
that Respondent controls directly, or
indirectly, from transferring, selling,
sharing, collecting, maintaining, or
storing personal information unless it
establishes and implements, and
thereafter maintains, a comprehensive
information security program that
protects the security, confidentiality,
and integrity of such personal
information.
Part II of the proposed order requires
Respondent to obtain initial and
biennial data security assessments for
twenty years.
Part III of the agreement requires
Respondent to disclose all material facts
to the assessor and prohibits
Respondent from misrepresenting any
fact material to the assessments required
by Part II.
Part IV requires Respondent to submit
an annual certification from a senior
corporate manager (or senior officer
responsible for its information security
program) that Respondent has
implemented the requirements of the
Order, is not aware of any material
noncompliance that has not been
corrected or disclosed to the
Commission, and includes a brief
description of any covered incident
involving unauthorized access to or
acquisition of personal information.
Part V requires Respondent to submit
a report to the Commission of its
discovery of any covered incident.
Part VI is a prohibition against
violating GLB.
Parts VII through X of the proposed
order are reporting and compliance
provisions, which include
recordkeeping requirements and
provisions requiring Respondent to
provide information or documents
necessary for the Commission to
monitor compliance. Part XI states that
the proposed order will remain in effect
for 20 years, with certain exceptions.
The purpose of this analysis is to aid
public comment on the proposed order.
It is not intended to constitute an
official interpretation of the complaint
or proposed order, or to modify in any
way the proposed order’s terms.
By direction of the Commission.
April J. Tabor,
Acting Secretary.
[FR Doc. 2019–12768 Filed 6–14–19; 8:45 am]
BILLING CODE 6750–01–P
VerDate Sep<11>2014
16:34 Jun 14, 2019
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Request for Information.
AGENCY:
AHRQ is re-issuing this
Request for Information to extend the
date for receipt of comments. AHRQ
invites public comment on its Request
for Information (RFI) to inform potential
revisions to the Consumer Assessment
of Healthcare Providers and Systems
Health Plan Survey 5.0. The Consumer
Assessment of Healthcare Providers and
Systems (CAHPS®) Health Plan Survey
5.0 is one of the CAHPS family of
surveys that assess patients’ experiences
with health care providers, in different
settings, and with health plans. The
CAHPS surveys cover topics that are
important to patients and that they are
best able to assess, such as the
communication with providers and
access to health care services.
This RFI requests public comment
regarding (1) the relevance and validity
of the questions on CAHPS Health Plan
Survey 5.0 (the Survey), and (2) any
user concerns about revisions to the
Survey.
SUMMARY:
Responses to the RFI must be
received no later than June 28, 2019.
ADDRESSES: Interested parties are to
submit comments electronically to
CAHPS1@westat.com with the subject
line HP RFI. Non-electronic responses
will also be accepted. Please mail to
CAHPS; Westat; 1600 Research Blvd.;
RB 1186S; Rockville, MD 20850.
FOR FURTHER INFORMATION CONTACT:
Questions may be addressed to Caren
Ginsberg, Director, CAHPS Division,
Center for Quality Improvement and
Patient Safety, caren.ginsberg@
ahrq.hhs.gov, or (301) 427–1894.
SUPPLEMENTARY INFORMATION: The last
update of the Survey was in May 2012.
AHRQ is considering an update to the
Survey to ensure that the Survey
questions continue to be relevant to
Survey sponsors, users, patients,
consumers, and other stakeholders.
AHRQ is not seeking information on
Survey administration methodology,
public reporting, or Survey length with
this request.
AHRQ is seeking information on
current uses of the Survey that reflects
organization-specific perspectives, the
DATES:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
impact of a potential Survey revision,
and areas of the Survey that should and
should not be modified. Respondents
should refer to the questions with
details on how such a Survey revision
might affect the organization(s) they
represent. Specific questions of interest
to AHRQ include, but are not limited to,
the following:
1. How and why does the
respondent’s organization use the
Survey? For example, is it used for
adults, children, or both? In what
languages is it administered? What
supplemental items, if any, are used
(e.g., children with chronic conditions
or others)?
2. What is working well/what are the
strengths of the Survey?
3. What content areas might be
missing from the Survey?
4. What content areas on the Survey
are no longer relevant or useful and
why?
5. Are there new topic areas the
Survey should address?
6. Should the Survey be revised, what
implications or barriers would there be
for the commenter’s organization to
implement a new version of the Survey?
7. What information/documentation
would be helpful to the respondent’s
organization in making a transition to a
future version of the Survey?
AHRQ is interested in all of the
questions listed above, but respondents
are welcome to address as many or as
few as they choose and to address
additional areas of interest not listed.
This RFI is for planning purposes only
and should not be construed as a policy,
solicitation for applications, or as an
obligation on the part of the
Government to provide support for any
ideas in response to it. AHRQ will use
the information submitted in response
to this RFI at its discretion, and will not
provide comments to any respondent’s
submission. However, responses to the
RFI may be reflected in future
solicitation(s) or policies. Respondents
are advised that the Government is
under no obligation to acknowledge
receipt of the information received or
provide feedback to respondents with
respect to any information submitted.
No proprietary, classified, confidential
or sensitive information should be
included in your response. The
Government reserves the right to use
any non-proprietary technical
information in any resultant
solicitation(s). The contents of all
submissions will be made available to
the public upon request. Submitted
E:\FR\FM\17JNN1.SGM
17JNN1
Federal Register / Vol. 84, No. 116 / Monday, June 17, 2019 / Notices
materials must be publicly available or
able to be made public.
Virginia Mackay-Smith,
Associate Director.
[FR Doc. 2019–12636 Filed 6–14–19; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Center for State, Tribal, Local and
Territorial Support (CSTLTS), CDC/
ATSDR Tribal Advisory Committee
(TAC) Meeting and 19th Biannual Tribal
Consultation Session
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The Centers for Disease
Control and Prevention (CDC)/Agency
for Toxic Substances and Disease
Registry (ATSDR), announces the
following meeting and Tribal
Consultation Session. The meetings are
being hosted by CDC/ATSDR in-person
only and are open to the public.
Attendees must pre-register for the
event by Friday, July 19, 2019, at the
following link: https://www.cdc.gov/
tribal/consultation-support/tac/
index.html.
SUMMARY:
The meeting will be held on
August 13–14, 2019.
DATES:
August 13, 2019
• 8:00 a.m.–9:30 a.m., EDT—Tribal
Caucus (Open only to elected tribal
officials and by invitation)
• 9:30 a.m.–5:45 p.m., EDT—CDC/
ATSDR TAC Meeting (Open to the
public)
August 14, 2019
• 8:00 a.m.–9:30 a.m., EDT—Tribal
Caucus (Open only to elected tribal
officials and by invitation)
• 9:30 a.m.–5:45 p.m., EDT—CDC/
ATSDR TAC Meeting (Open to the
public)
Harrah’s Cherokee, 77
Casino Drive, Cherokee, NC 28719.
FOR FURTHER INFORMATION CONTACT:
Captain Carmen Clelland, PharmD,
MPA, MPH, Director, Office of Tribal
Affairs and Strategic Alliances, Center
for State, Tribal, Local and Territorial
Support, CDC, 4770 Buford Highway,
Mailstop V18–4, Atlanta, GA 30341–
3717; telephone (404) 498–0300;
Tribalsupport@cdc.gov.
khammond on DSKBBV9HB2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
16:34 Jun 14, 2019
Jkt 247001
This
meeting is being held in accordance
with Presidential Executive Order No.
13175, November 6, 2000, and the
Presidential Memorandum of November
5, 2009, and September 23, 2004,
Consultation and Coordination with
Indian Tribal Governments.
Purpose: The purpose of the TAC and
consultation meetings is to advance
CDC/ATSDR support for and
collaboration with American Indian and
Alaska Native (AI/AN) tribes and to
improve the health of AI/AN tribes by
pursuing goals that include assisting in
eliminating the health disparities faced
by AI/AN tribes; ensuring that access to
critical health and human services and
public health services is maximized to
advance or enhance the social, physical,
and economic status of American Indian
and Alaskan Native people; and
promoting health equity for all Indian
people and communities. To advance
these goals, CDC/ATSDR conducts
government-to-government
consultations with elected tribal
officials or their authorized
representatives. Consultation is an
enhanced form of communication that
emphasizes trust, respect, and shared
responsibility. It is an open and free
exchange of information and opinion
among parties that leads to mutual
understanding.
Matters To Be Considered: The agenda
will include, but not limited to,
discussions on securing sustainable
funding to Indian Country, ensuring a
tribal voice in CDC policy and
programs, and current CDC priorities.
The discussion topics are subject to
revision as prioritize change. The TAC
Meeting and Biannual Tribal
Consultation Session will provide
opportunities for elected AI/AN tribal
officials to speak openly about the
public health issues affecting their tribal
nations. Tribal nations also will have an
opportunity to present testimony about
tribal public health issues. All elected
tribal officials are encouraged to submit
written testimony by 5:00 p.m., EDT,
Friday, July 19, 2019 to Captain Carmen
Clelland, Pharm, MPA, MPH, Director,
Office of Tribal Affairs and Strategic
Alliances via mail to 4770 Buford
Highway, Mailstop V18–4, Atlanta, GA
30341–3717, or by email at
TribalSupport@cdc.gov. Elected tribal
officials can find guidance to assist in
developing tribal testimony for CDC/
ATSDR at www.cdc.gov/tribal/
consultation-support/. Please
submit tribal testimony on official tribal
letterhead.
Based on the number of elected tribal
officials giving testimony and the time
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
28057
available, it may be necessary to limit
the time for each presenter.
Additional information about the
TAC, CDC/ATSDR’s Tribal Consultation
Policy, and previous meetings can be
found at www.cdc.gov/tribal/
consultataion-support/.
Agenda items are subject to change as
priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–12724 Filed 6–14–19; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–N–0721]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Accreditation of
Third-Party Certification Bodies To
Conduct Food Safety Audits and Issue
Certifications
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing that a proposed collection
of information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by July 17,
2019.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, Fax: 202–
395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0331. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Operations,
SUMMARY:
E:\FR\FM\17JNN1.SGM
17JNN1
]]>Agencies
[Federal Register Volume 84, Number 116 (Monday, June 17, 2019)]
[Notices]
[Pages 28056-28057]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12636]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Request for Information.
-----------------------------------------------------------------------
SUMMARY: AHRQ is re-issuing this Request for Information to extend the
date for receipt of comments. AHRQ invites public comment on its
Request for Information (RFI) to inform potential revisions to the
Consumer Assessment of Healthcare Providers and Systems Health Plan
Survey 5.0. The Consumer Assessment of Healthcare Providers and Systems
(CAHPS[supreg]) Health Plan Survey 5.0 is one of the CAHPS family of
surveys that assess patients' experiences with health care providers,
in different settings, and with health plans. The CAHPS surveys cover
topics that are important to patients and that they are best able to
assess, such as the communication with providers and access to health
care services.
This RFI requests public comment regarding (1) the relevance and
validity of the questions on CAHPS Health Plan Survey 5.0 (the Survey),
and (2) any user concerns about revisions to the Survey.
DATES: Responses to the RFI must be received no later than June 28,
2019.
ADDRESSES: Interested parties are to submit comments electronically to
[email protected] with the subject line HP RFI. Non-electronic
responses will also be accepted. Please mail to CAHPS; Westat; 1600
Research Blvd.; RB 1186S; Rockville, MD 20850.
FOR FURTHER INFORMATION CONTACT: Questions may be addressed to Caren
Ginsberg, Director, CAHPS Division, Center for Quality Improvement and
Patient Safety, [email protected], or (301) 427-1894.
SUPPLEMENTARY INFORMATION: The last update of the Survey was in May
2012. AHRQ is considering an update to the Survey to ensure that the
Survey questions continue to be relevant to Survey sponsors, users,
patients, consumers, and other stakeholders. AHRQ is not seeking
information on Survey administration methodology, public reporting, or
Survey length with this request.
AHRQ is seeking information on current uses of the Survey that
reflects organization-specific perspectives, the impact of a potential
Survey revision, and areas of the Survey that should and should not be
modified. Respondents should refer to the questions with details on how
such a Survey revision might affect the organization(s) they represent.
Specific questions of interest to AHRQ include, but are not limited to,
the following:
1. How and why does the respondent's organization use the Survey?
For example, is it used for adults, children, or both? In what
languages is it administered? What supplemental items, if any, are used
(e.g., children with chronic conditions or others)?
2. What is working well/what are the strengths of the Survey?
3. What content areas might be missing from the Survey?
4. What content areas on the Survey are no longer relevant or
useful and why?
5. Are there new topic areas the Survey should address?
6. Should the Survey be revised, what implications or barriers
would there be for the commenter's organization to implement a new
version of the Survey?
7. What information/documentation would be helpful to the
respondent's organization in making a transition to a future version of
the Survey?
AHRQ is interested in all of the questions listed above, but
respondents are welcome to address as many or as few as they choose and
to address additional areas of interest not listed. This RFI is for
planning purposes only and should not be construed as a policy,
solicitation for applications, or as an obligation on the part of the
Government to provide support for any ideas in response to it. AHRQ
will use the information submitted in response to this RFI at its
discretion, and will not provide comments to any respondent's
submission. However, responses to the RFI may be reflected in future
solicitation(s) or policies. Respondents are advised that the
Government is under no obligation to acknowledge receipt of the
information received or provide feedback to respondents with respect to
any information submitted. No proprietary, classified, confidential or
sensitive information should be included in your response. The
Government reserves the right to use any non-proprietary technical
information in any resultant solicitation(s). The contents of all
submissions will be made available to the public upon request.
Submitted
[[Page 28057]]
materials must be publicly available or able to be made public.
Virginia Mackay-Smith,
Associate Director.
[FR Doc. 2019-12636 Filed 6-14-19; 8:45 am]
BILLING CODE 4160-90-P
